Contrasting Oncology Pharma (OTCMKTS:ONPH) & Confluent (NASDAQ:CFLT)

Confluent (NASDAQ:CFLT) and Oncology Pharma (OTCMKTS:ONPH) are both business services companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, analyst recommendations, earnings and risk.

Valuation & Earnings

This table compares Confluent and Oncology Pharma’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Confluent	$865.59 million	6.86	-$442.75 million	($1.25)	-14.94
Oncology Pharma	N/A	N/A	N/A	N/A	N/A

Oncology Pharma has lower revenue, but higher earnings than Confluent.

Insider and Institutional Ownership

78.1% of Confluent shares are held by institutional investors. 13.8% of Confluent shares are held by company insiders. Comparatively, 18.0% of Oncology Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for Confluent and Oncology Pharma, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Confluent	1	6	22	0	2.72
Oncology Pharma	0	0	0	0	N/A

Confluent presently has a consensus price target of $31.04, suggesting a potential upside of 66.23%.

Profitability

This table compares Confluent and Oncology Pharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Confluent	-42.70%	-38.46%	-12.95%
Oncology Pharma	N/A	N/A	N/A

Risk and Volatility

Confluent has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Oncology Pharma has a beta of -1.04, meaning that its stock price is 204% less volatile than the S&P 500.

About Confluent

Confluent, Inc. operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software. It offers connectors for existing applications, and IT and cloud infrastructure; Apache Flink services that allows teams to create reusable data streams that can be delivered real-time; ksqlDB, a data-in-motion database that allows users to build data-in-motion applications using a few SQL statements; stream governance, a managed data governance suite that is designed for the intricacies of streaming data, which allows teams to accelerate data streaming initiatives without bypassing controls for risk management and regulatory compliance; and stream designer which builds streaming data pipelines visually. In addition, the company offers professional services comprising packaged and residency offerings; education offerings consisting of instructor-led and self-paced training and certification guidance, technical resources, and access to hands-on training and certification exams; and certification programs. It serves banking and financial services industries, as well as retail and e-commerce, manufacturing, automotive, communication service providers, gaming, public sector, insurance, and technology industries. The company was formerly known as Infinitem, Inc. and changed its name to Confluent, Inc. in September 2014. Confluent, Inc. was incorporated in 2014 and is headquartered in Mountain View, California.

About Oncology Pharma

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.